£2.5m fundraise will help research into malaria cures
Date added:
17/02/2016
RESEARCH and development specialists Arcis Biotechnology says it has raised £2.5m in an oversubscribed fundraise, supported by existing shareholders and new investors. Now valued at circa £15m, the company based at Daresbury in Cheshire will continue to commercialise its ground-breaking R&D-led portfolio of products, including its novel malaria diagnostic which is intended to help detect the disease quickly, in its very early stages, and at a low cost. Peter Whitehurst, chief executive of Arcis Biotechnology, said: ...
Back to all news